Neuronetics, Inc. (STIM): who owns it and who trades it
As of Nov 16, 2026, STIM insiders reported 16 open-market sales worth $4.8M and 16 purchases worth $4.9M in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Jorey Chernett (10% owner), with $4.5M. 5 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Neuronetics
From the latest filingsOverall: about as much buying as selling. Famous investors mostly bought. Funds and insiders were close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns STIM
87 funds and institutions reported STIM shares worth $48.4M at the end of Q2 2026, about 54% of the company. The largest holder is Madryn Asset Management, LP with 26.8%.
Funds and institutions (13F) 54%Everyone else 46%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| Madryn Asset Management, LP | 18.54M | 26.76% | $24.1M | +0% |
| UBS Group AG | 2.28M | 3.29% | $3M | -21% |
| Wexford Capital LP | 2.00M | 2.89% | $2.6M | +186% |
| FourWorld Capital Management LLC | 1.74M | 2.52% | $2.3M | +17% |
| Lane Generational LLC | 1.63M | 2.36% | $2.1M | -8% |
| Vanguard Capital Management LLC | 1.51M | 2.18% | $2M | -26% |
| Masters Capital Management LLC | 1.00M | 1.44% | $1.3M | No change |
| AdvisorShares Investments LLC | 742,795 | 1.07% | $966K | +20% |
| Ikarian Capital, LLC | 701,182 | 1.01% | $912K | No change |
| BlackRock, Inc. | 596,622 | 0.86% | $776K | -74% |
| HighTower Advisors, LLC | 563,741 | 0.81% | $733K | +0% |
| Marshall Wace, LLP | 485,692 | 0.70% | $631K | New |
| Geode Capital Management, LLC | 458,474 | 0.66% | $596K | -52% |
| Citadel Advisors LLC | 421,903 | 0.61% | $548K | +451% |
| Dauntless Investment Group, LLC | 369,187 | 0.53% | $480K | +37% |
| State Street Corp | 290,299 | 0.42% | $377K | -66% |
| Centiva Capital, LP | 285,913 | 0.41% | $372K | +69% |
| Vanguard Fiduciary Trust Co | 264,734 | 0.38% | $344K | +3% |
| Goldman Sachs Group Inc | 264,088 | 0.38% | $343K | +13% |
| JBF Capital, Inc. | 233,166 | 0.34% | $303K | No change |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, STIM insiders reported $4.9M of open-market purchases and $4.8M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | Jorey Chernett | 10% owner | Sale | 2.19M | $1.15 | $2.5M | Form 4 |
| Nov 12, 2026 | Jorey Chernett | 10% owner | Sale | 706,840 | $1.43 | $1M | Form 4 |
| Nov 11, 2026 | Jorey Chernett | 10% owner | Sale | 86,757 | $1.61 | $140K | Form 4 |
| Nov 9, 2026 | Jorey Chernett | 10% owner | Sale | 103,959 | $2.06 | $214K | Form 4 |
| Nov 9, 2026 | Jorey Chernett | 10% owner | Purchase | 40,000 | $1.99 | $79.6K | Form 4 |
| Nov 6, 2026 | Jorey Chernett | 10% owner | Sale | 250,804 | $2.39 | $599K | Form 4 |
| Oct 30, 2026 | Jorey Chernett | 10% owner | Purchase | 18,000 | $2.27 | $40.9K | Form 4 |
| Aug 14, 2026 | Jorey Chernett | 10% owner | Purchase | 14,000 | $3.16 | $44.2K | Form 4 |
| Jul 14, 2026 | Jorey Chernett | 10% owner | Purchase | 35,000 | $1.78 | $62.3K | Form 4 |
| May 19, 2026 | Jorey Chernett | 10% owner | Purchase | 100,000 | $1.17 | $117K | Form 4 |
| May 12, 2026 | Jorey Chernett | 10% owner | Purchase | 475,000 | $1.34 | $636K | Form 4 |
| Apr 21, 2026 | Jorey Chernett | 10% owner | Purchase | 100,000 | $1.51 | $151K | Form 4 |
| Apr 20, 2026 | Jorey Chernett | 10% owner | Purchase | 100,000 | $1.58 | $158K | Form 4 |
| Mar 30, 2026 | Jorey Chernett | 10% owner | Purchase | 385,442 | $1.25 | $482K | Form 4 |
| Mar 27, 2026 | Jorey Chernett | 10% owner | Purchase | 500,000 | $1.35 | $675K | Form 4 |
| Mar 26, 2026 | Jorey Chernett | 10% owner | Purchase | 25,000 | $1.44 | $36K | Form 4 |
| Mar 25, 2026 | Jorey Chernett | 10% owner | Purchase | 125,000 | $1.40 | $175K | Form 4 |
| Mar 20, 2026 | Jorey Chernett | 10% owner | Purchase | 169,472 | $1.41 | $239K | Form 4 |
| Mar 19, 2026 | Steven Pfanstiel | CFO | Sale | 8,569 | $1.34 | $11.5K | Form 4 |
| Mar 19, 2026 | Steven Pfanstiel | CFO | Sale | 16,431 | $1.34 | $22K | Form 4 |
| Mar 19, 2026 | Keith J Sullivan | Other | Sale | 46,289 | $1.34 | $62K | Form 4 |
| Mar 19, 2026 | William Andrew Macan | Vice president | Sale | 16,005 | $1.34 | $21.4K | Form 4 |
| Mar 19, 2026 | Jorey Chernett | 10% owner | Purchase | 450,000 | $1.33 | $598K | Form 4 |
| Mar 18, 2026 | Jorey Chernett | 10% owner | Purchase | 607,400 | $1.35 | $820K | Form 4 |
| Mar 17, 2026 | Jorey Chernett | 10% owner | Purchase | 531,000 | $1.16 | $616K | Form 4 |
| Mar 4, 2026 | William Andrew Macan | Vice president | Sale | 609 | $1.34 | $816 | Form 4 |
| Feb 26, 2026 | William Andrew Macan | Vice president | Sale | 3,427 | $1.35 | $4.6K | Form 4 |
| Feb 26, 2026 | Keith J Sullivan | CEO | Sale | 8,452 | $1.35 | $11.4K | Form 4 |
| Feb 12, 2026 | Keith J Sullivan | CEO | Sale | 33,847 | $1.65 | $55.8K | Form 4 |
| Feb 12, 2026 | William Andrew Macan | Vice president | Sale | 14,120 | $1.65 | $23.3K | Form 4 |
| Feb 10, 2026 | William Andrew Macan | Vice president | Sale | 3,485 | $1.55 | $5.4K | Form 4 |
| Feb 10, 2026 | Keith J Sullivan | CEO | Sale | 40,976 | $1.55 | $63.5K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Jorey Chernett | 10% owner | $4.9M | $4.5M | Nov 13, 2026 |
| Keith J Sullivan | President and CEO, Director | – | $193K | Mar 19, 2026 |
| William Andrew Macan | EVP, CLO and CS | – | $55.6K | Mar 19, 2026 |
| Steven Pfanstiel | EVP, CFO and Treasurer | – | $33.5K | Mar 19, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
STIM short interest
Moderate short interest. 8.6% of STIM shares are sold short: about 1 share in 12. Over the last 12 reports the number of shares short went down 31%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 6.66M STIM shares were sold short, 8.6% of the shares outstanding, down 7.6% from the report before. At the average daily volume of 673,520 shares, buying them all back would take about 9.9 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 6.66M | 8.57% | -8% | 673,520 | 9.9 |
| Oct 15, 2026 | 7.21M | 9.46% | +2% | 764,547 | 9.4 |
| Sep 30, 2026 | 7.07M | 9.28% | +14% | 887,720 | 8.0 |
| Sep 15, 2026 | 6.21M | 8.15% | -7% | 1.66M | 3.7 |
| Aug 31, 2026 | 6.67M | 8.75% | -17% | 1.02M | 6.5 |
| Aug 14, 2026 | 8.05M | 10.56% | -14% | 4.94M | 1.6 |
| Jul 31, 2026 | 9.33M | 13.47% | -0% | 2.71M | 3.4 |
| Jul 15, 2026 | 9.37M | 13.53% | +22% | 1.21M | 7.8 |
| Jun 30, 2026 | 7.68M | 11.09% | -22% | 1.63M | 4.7 |
| Jun 15, 2026 | 9.81M | 14.16% | -1% | 1.30M | 7.6 |
| May 29, 2026 | 9.88M | 14.26% | +2% | 2.91M | 3.4 |
| May 15, 2026 | 9.64M | 13.91% | -8% | 3.35M | 2.9 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Neuronetics company events
Neuronetics filed 16 reports on Form 8-K in the last 12 months, 8 of them about an important change (leadership). The latest was on Nov 10, 2026.
- Nov 10, 2026AgreementAs previously disclosed, on July 25, 2024, Neuronetics, Inc. entered into a Credit Agreement and Guaranty (as amended, the “Existing Credit Agreement”) with Perceptive Credit Holdings IV, LP, as administrative agent and a lender, and the other lenders party thereto. Filing
- Nov 4, 2026ResultsReleased financial results. Filing
- Aug 17, 2026LeadershipIn connection with Mr. Naor’s appointment (as described below), Francis X. Brown III’s appointment as Neuronetics, Inc.’s interim principal financial and accounting officer ended. Filing
- Aug 11, 2026ResultsReleased financial results. Filing
- Jul 20, 2026LeadershipNeuronetics, Inc. and W. Andrew Macan, who has served as Executive Vice President, Chief Legal Officer, and Corporate Secretary and in various other similar capacities since January 21, 2020, entered into a Separation Agreement. Filing
- Jun 23, 2026LeadershipThe board of directors of the Company promoted Cory Anderson from the position of Senior Vice President, Chief Technology Officer to the position of Executive Vice President, General Manager of Greenbrook effective July 1, 2026. Filing
- May 29, 2026VoteReported shareholder vote results. Filing
- May 22, 2026LeadershipNeuronetics, Inc. previously announced that the Board appointed Francis X. Brown III as the Company’s Interim Principal Financial and Accounting Officer effective as of May 5, 2026 pursuant to an amended and restated consulting agreement with Mr. Brown dated as of April 22, 2026. Filing
- May 5, 2026ResultsReleased financial results. Filing
- Apr 6, 2026LeadershipSteven E. Pfanstiel, who has served as Executive Vice President, Chief Financial Officer, and Treasurer since July 15, 2025, informed the Company of his intention to resign on May 1, 2026. Filing
- Mar 17, 2026LeadershipThe board of directors of the Company appointed Daniel L. Reuvers as the Company’s President and Chief Executive Officer effective on the date that Mr. Reuvers commences employment with the Company, which is expected to be March 23, 2026. Filing
- Mar 2, 2026AgreementAs previously disclosed on August 13, 2024, simultaneously with the execution of that certain Arrangement Agreement by and between Greenbrook TMS Inc. and Neuronetics, Inc., Madryn Asset Management LP and its affiliates and Neuronetics entered into a Registration Rights Agreement, pursuant to which… Filing
- Feb 25, 2026LeadershipThe Compensation Committee of the Board of Directors of Neuronetics, Inc. approved annual cash incentive compensation awards for Steven E. Pfanstiel, the Company’s Executive Vice President, Chief Financial Officer, and Treasurer, and W. Andrew Macan, the Company’s Executive Vice President, Chief… Filing
- Feb 10, 2026ResultsReleased financial results. Filing
- Jan 22, 2026AgreementAs previously disclosed, on July 25, 2024, Neuronetics, Inc. entered into a Credit Agreement and Guaranty with Perceptive Credit Holdings IV, LP, as collateral agent and other lenders defined in the agreement. Filing
- Jan 6, 2026LeadershipThe Compensation Committee of the Board of Directors of Neuronetics, Inc. approved cash awards and restricted stock unit incentive compensation awards for Steven E. Pfanstiel, the Company’s Executive Vice President, Chief Financial Officer and Treasurer, and W. Andrew Macan, the Company’s Executive… Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Neuronetics financials
Famous investors that hold STIM
5 of the 50 well-known investors we track reported holding STIM in their latest 13F filing. The largest position is Steve Cohen's, worth $9.7M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Steve Cohen · Point72 Asset Management | Q3 2026 | 4.16M | $9.7M | 0.0% | New |
| Ken Griffin · Citadel Advisors | Q3 2026 | 639,774 | $1.5M | 0.0% | +52% |
| Jim Simons · Renaissance Technologies | Q3 2026 | 424,400 | $993K | 0.0% | New |
| Israel Englander · Millennium Management | Q3 2026 | 342,434 | $801K | 0.0% | +72% |
| Paul Tudor Jones · Tudor Investment Corp | Q3 2026 | 48,343 | $113K | 0.0% | -61% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named STIM in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 16, 2026 | Chernett Jorey | 13D/A | 2.7% |
| Nov 16, 2026 | MADRYN ASSET MANAGEMENT, LP | 13D/A | 21.6% |
| Nov 16, 2026 | MADRYN ASSET MANAGEMENT, LP | 13D/A | 21.6% |
| Nov 16, 2026 | Chernett Jorey | 13D/A | 2.7% |
Questions about Neuronetics, Inc. (STIM) stock
Who owns the most STIM stock?
The largest reported owner of Neuronetics, Inc. (STIM) is Madryn Asset Management, LP, with 26.8% of the company. In total, 87 funds and institutions reported holding STIM at the end of Q2 2026, together about 54% of the shares. See the largest owners.
Are STIM insiders buying or selling?
In the last 12 months, STIM insiders reported 16 open-market purchases worth $4.9M and 16 sales worth $4.8M. The latest trade was on Nov 13, 2026. See every trade.
What is the short interest in STIM?
As of Oct 30, 2026, 6.66M STIM shares were sold short, 8.6% of the shares outstanding, down 7.6% from the report before. At the average daily volume of 673,520 shares, buying them all back would take about 9.9 trading days (days to cover). See the history.
Which famous investors hold STIM?
5 of the 50 well-known investors we track reported STIM in their latest 13F filing, including Steve Cohen, Ken Griffin, Jim Simons. The largest position is worth $9.7M. See all holders.
Executive pay
Neuronetics's chief executive was paid a total of $4.4M for the year ended Dec 31, 2025, up 80% from $2.4M the year before. In the last 12 months, Neuronetics's executives and directors bought no stock on the open market and sold $282K.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.